Gemini vitamin D analogue BXL0124 inhibits CD44-STAT3-mediated breast cancer invasion and metastasis by decreasing CD44 expression and STAT3 activation, as well as preventing CD44 binding to JAK2 and STAT3 in the cytoplasm (80). Here, JAK2 is linked to breast cancer.